Article Name Predictive Diagnostics
Singapore's Mechanobiology Institute Secures S$49 Million for Advancing Biomedical Innovations
The National University of Singapore's Mechanobiology Institute (MBI) has recently secured a substantial S$49 million funding boost from the National Research Foundation (NRF) to propel advancements in mechanobiology. This funding, spread over seven years starting from December 2023, will be instrumental in conducting research to address age-related loss of biomechanical functions, particularly focusing on ailments such as infertility, chronic inflammatory diseases, muscle atrophy, and cancer.
29th January, 2024
BD Advances Women's Health Equity in Kenya with Cancer Screening
Collaboration with Kenya Ministry of Health National Cancer Institute Aims to Expand Access to Diagnostics, Reduce Cervical Cancer Rates
26th January, 2024
Biomedical Innovation: Answer for Climate-sensitive Diseases
The world is finally paying attention to the impact of climate change on neglected diseases. What we need now is medical innovation.
08th January, 2024
“The Open Innovation Program has become a trend in the molecular diagnostics industry”
Established in 2000, South Korea based Seegene Inc is a leader in molecular diagnostics and achieved remarkable financial success with over $1 billion in revenue and 65 per cent gross margins. With a mission for a disease-free world and proactive pandemic prevention, Seegene seamlessly integrates high multiplex diagnostic assays with automated testing systems. In an interaction with BioSpectrum & MedTech Spectrum, Dr Seong-Youl Kim, Seegene's Senior Vice President, shares insights on the company, the molecular diagnostics landscape, challenges and opportunities etc.
08th January, 2024
Targeted Battle Against HPV
Since the launch of the global strategy against cervical cancer in 2020, the World Health Organization (WHO) has accelerated the initiative by virtue of commitments and strategies offered by governments and organisations worldwide. Australia is on track to become one of the first nations to achieve this, and countries like Bangladesh and Indonesia have introduced HPV vaccines. Let's examine Asia's efforts in eliminating cervical cancer and whether the continent is on track to meet WHO’s targets by 2030.
08th January, 2024
Varian & Nova Scotia Health Forge Groundbreaking Oncology Partnership for Cancer Care Advancements
Varian, a Siemens Healthineers company, and Nova Scotia Health have formed an unprecedented 10-year, $175 million CAD multi-disciplinary oncology partnership (MDOP) designed to deliver value across the Nova Scotia Health system by accelerating the patient journey from screening to survivorship.
05th January, 2024
Urology of Virginia Announces New Chief Executive Officer
Dr. Joshua Langston Assumes Role of Managing Partner and CEO at Urology of Virginia
02nd January, 2024
Lucem Health Launches Reveal for Faster AFib-Related Stroke Treatment
Groundbreaking Solution Identifies Undiagnosed AFib and Speeds Treatments Proven to Prevent Strokes
18th December, 2023
TMRW Life Sciences Expands Globally Entering UK Fertility Market
The Hewitt Fertility Centre is the First UK Clinic to Adopt TMRW's State-of-the-Art Technology for the Safe Management of Frozen Eggs and Embryos Providing a New Standard of Care for Fertility Patients
18th December, 2023
Revvity launches easy-to-use molecular diagnostics workflow for newborn screening
EONIS Q System enabling faster, simplified newborn screening for SMA and SCID
11th December, 2023
BD Launches Advanced Vascular Access Ultrasound System Designed to Improve Clinician Efficiency
SiteRite™ 9 Ultrasound System Delivers Enhanced Image Quality and Vessel Assessment Tools to Aid in First Attempt IV Insertion Success
04th December, 2023
Mayo Clinic Labs and Progentec® Partner for Advanced Autoimmune Biomarker Testing
The collaboration aims to increase accessibility for providers and patients across the U.S. and select global markets.
15th November, 2023
University of Miami Health System to Maximize Patient Care with New Aidoc AI Technology
AI-driven care diagnostic imaging and care coordination to streamline physician workflows for timely and efficient patient care delivery
15th November, 2023
Disruptive Technologies and New Industry Initiatives for Diabetes Management
Asia will continue to be a large and rapidly growing market for diabetes care technologies. To be competitive and successful in the aggressive market with numerous large and startup companies, players will need large funds, a broad portfolio with desirable differentiators and a strong distribution network. Low-cost products, subscription-based solutions, reimbursement policies and training of patients and physicians will be required to promote the adoption among low income and middle-income regions. Large players are very intent on tapping the large market potential in Asia. Many global companies have set up local presence in Asian countries and local production through original equipment manufacturer (OEM) partners in the countries to bring down the cost of their solutions, and more companies are expected to follow
06th November, 2023
Pearl and Gamma Tech Partner to Bring AI to Dentists across Australia and New Zealand
Gamma Tech will distribute Pearl’s flagship AI solution, Second Opinion®, to the ANZ dental markets
02nd November, 2023
Japan-based Shimadzu unveils integrated system for urine volume measurement
Measuring urine volume based on the difference in body weight before and after urination, eliminating the need for urine collection
26th October, 2023
Roche Acquires Telavant and TL1A Antibody for Inflammatory Bowel Disease
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the entry into a definitive agreement to acquire Telavant Holdings, Inc. (Telavant), a Roivant company, owned by Roivant Sciences Ltd. and Pfizer Inc.
24th October, 2023
Medtronic FDA Approved for Extravascular Defibrillator for Heart Rhythms
First-of-its-kind Aurora EV-ICD™ system offers single device, single procedure with lead placed outside of heart and veins
24th October, 2023
Medtech Special
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer